← Leaderboards
Xinjiang Wang
Roswell Park Cancer Institute Corp
$1,913,000
Attributed
$1,913,000
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $393K · FY2017–21$500K$375K$250K$125K$0
'17
'18
'19
'20
'21
Funding mix
By agency
NIH$1,913,000 · 1
By mechanism
R01$1,913,000 · 1
Top collaborators
No co-investigators on record.
Most similar at Roswell Park Cancer Institute Corp
Same institution · by research overlap
- Steven H Bernstein$2,820,683
- Daniel Michael Green$92,024
- Qiang Li$1,428,645
- Martin L Brecher$381,449
- Scott I. Abrams$11,133,748
Others in their field
Other Emerging Leaders on “S Lymphoma”
- Gautam (george) Mitra · Leidos Biomedical Research, Inc.$53,523,213
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$22,138,591
- Leonard Freedman · Leidos Biomedical Research, Inc.$10,332,151
- Kathleen Nicol · Research Inst Nationwide Children'S Hosp$7,187,946
- Javeed Iqbal · University Of Nebraska Medical Center$5,566,166
- John Karijolich · Vanderbilt University Medical Center$5,446,739
Research focus
S LymphomaAntitumor EffectCessation Of LifeApoptoticBaseB-Cell LymphomasApoptosisAdultBindingBiochemistryBiophysical AnalysisCell Death InductionCell LineCellsAcquired Drug ResistanceChemotherapyClinicClinical TranslationCollaborative TrialComplexCoupledCultured CellsCyclophosphamideCytotoxicity
Grant awards (5)
Targeting Mdm2-MdmX E3 Ligase for Treatment of Drug-Resistant Lymphoma$392,992
R01 · FY2021 · CA · contact PI
Targeting Mdm2-MdmX E3 Ligase for Treatment of Drug-Resistant Lymphoma$392,992
R01 · FY2020 · CA · contact PI
Targeting Mdm2-MdmX E3 Ligase for Treatment of Drug-Resistant Lymphoma$362,546
R01 · FY2019 · CA · contact PI
Targeting Mdm2-MdmX E3 Ligase for Treatment of Drug-Resistant Lymphoma$373,760
R01 · FY2018 · CA · contact PI
Targeting Mdm2-MdmX E3 Ligase for Treatment of Drug-Resistant Lymphoma$390,710
R01 · FY2017 · CA · contact PI